These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients. Repo-Tiihonen E, Eloranta A, Hallikainen T, Tiihonen J. Neuropsychobiology; 2005; 51(4):173-6. PubMed ID: 15870506 [Abstract] [Full Text] [Related]
6. Pharmacokinetic studies of antipsychotics in healthy volunteers versus patients. Cutler NR. J Clin Psychiatry; 2001; 62 Suppl 5():10-3; discussion 23-4. PubMed ID: 11305842 [Abstract] [Full Text] [Related]
7. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies. Zipris P, Melamed Y, Weizman A, Bleich A. Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812 [Abstract] [Full Text] [Related]
8. Prescribing and monitoring clozapine in Christchurch. McKean A, Vella-Brincat J, Begg E. Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375 [Abstract] [Full Text] [Related]
10. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1330-6. PubMed ID: 17618026 [Abstract] [Full Text] [Related]
11. Branded versus generic clozapine: bioavailability comparison and interchangeability issues. Lam YW, Ereshefsky L, Toney GB, Gonzales C. J Clin Psychiatry; 2001 Aug 15; 62 Suppl 5():18-22; discussion 23-4. PubMed ID: 11305844 [Abstract] [Full Text] [Related]
12. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients. Wong JO, Leung SP, Mak T, Ng RM, Chan KT, Hon-Kee Cheung H, Choi WK, Lai J, Wai-Kiu Tsang A. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar 15; 30(2):251-64. PubMed ID: 16316716 [Abstract] [Full Text] [Related]
13. Increase in plasma levels of clozapine after addition of isoniazid. Angelini MC, MacCormack-Gagnon J, Dizio S. J Clin Psychopharmacol; 2009 Apr 15; 29(2):190-1. PubMed ID: 19512988 [No Abstract] [Full Text] [Related]
14. Implications for anaesthesia in a patient established on clozapine treatment. Doherty J, Bell PF, King DJ. Int J Obstet Anesth; 2006 Jan 15; 15(1):59-62. PubMed ID: 16256331 [Abstract] [Full Text] [Related]
15. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ. Ann Pharmacother; 2008 Jun 15; 42(6):852-60. PubMed ID: 18477732 [Abstract] [Full Text] [Related]
16. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms. Kämpf P, Agelink MW, Naber D. Pharmacopsychiatry; 2005 Jan 15; 38(1):39-40. PubMed ID: 15706467 [No Abstract] [Full Text] [Related]
18. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia. Popovic V, Doknic M, Maric N, Pekic S, Damjanovic A, Miljic D, Popovic S, Miljic N, Djurovic M, Jasovic-Gasic M, Dieguez C, Casanueva FF. Neuroendocrinology; 2007 Jan 15; 85(4):249-56. PubMed ID: 17570902 [Abstract] [Full Text] [Related]
19. [Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?]. van Gool AR, van der Velden MT, Oosten AW, van Meerten E, Verhoeven WM, Loonen AJ. Tijdschr Psychiatr; 2008 Jan 15; 50(10):673-8. PubMed ID: 18951346 [Abstract] [Full Text] [Related]
20. Comparison of the bioequivalence of generic versus branded clozapine. Ereshefsky L, Glazer WM. J Clin Psychiatry; 2001 Jan 15; 62 Suppl 5():25-7. PubMed ID: 11305845 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]